Bayer completed the sale of the Dr. Scholl’s™ business to Yellow Wood Partners for a purchase price of 585 million U.S. dollars. Dr. Scholl’s™ generated sales of 234 million U.S. dollars in 2018.
The brand has an over 110-year heritage with unmatched brand equity in the foot care category, and the #1 sales position in the most attractive segments, according to Bayer. The company took ownership of Dr. Scholl’s™ in late 2014.
Yellow Wood Partners has acquired the product rights to Dr. Scholl’s™ in the Americas and taken over approximately 30 dedicated brand personnel in the United States, including Sales and Marketing, Research & Development and others.